Tang Kun, Li Jia, Wang Yucheng, Guo Zhangbao, Yang Yun, Guo Fangliang, Cai Yin, Liu Wenhua
Department of Neurology, Wuhan No.1 Hospital, Wuhan, Hubei, China.
Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Front Neurol. 2025 Jul 31;16:1598156. doi: 10.3389/fneur.2025.1598156. eCollection 2025.
Stroke-associated pneumonia (SAP) often occurs after ischemic stroke. A deterioration in SAP manifests itself in a decreased partial pressure oxygen (PaO)/fraction of inspired oxygen (FiO) ratio, indicating gas exchange dysfunction. We aimed to investigate independent predictors and outcomes of SAP with low PaO/FiO ratio among patients with acute large vessel occlusion (ALVO) undergoing endovascular therapy.
We retrospectively analyzed the prospective data of consecutive adult post-interventional patients with ALVO admitted to neuro-intensive care units in Wuhan No. 1 Hospital from December 2020 to December 2022. Patients developing SAP without coronavirus disease 2019 were included in this study and divided into two subgroups: PaO/FiO ratio > 240 and ≤ 240. The primary outcome was favorable neuro-function at 90 days (modified Rankin Scale score of 0-2). Secondary outcomes included hospitalization days, occurrence of symptomatic intracerebral hemorrhage, and 90-day mortality. The independent risk factors and prognosis for SAP with PaO/FiO ratio ≤ 240 were identified by logistic regression analyses.
A total of 159 subjects developing SAP were included in this study: 53 with PaO/FiO ratio > 240 and 106 with ratio ≤ 240. Compared to subjects with PaO/FiO ratio > 240, those with PaO/FiO ratio ≤ 240 had older ages, higher baseline National Institutes of Health Stroke Scales scores, larger proportions of baseline Glasgow Coma Scale (GCS) score of 3-8 and grade of kobuta water swallow test ≥ 3, higher white blood cell (WBC) counts (all values <0.05). The independent predictors for SAP with PaO/FiO ratio ≤ 240 included ages (adjusted odds ratio [OR], 1.043; 95% confidential interval [CI], 1.011-1.077; = 0.009), baseline GCS scores of 3-8 (adjusted OR, 2.802; 95% CI, 1.214-6.465; = 0.016), and ln-transformed WBC counts after SAP diagnosis (adjusted OR, 3.977; 95% CI, 1.226-12.896; = 0.021). SAP with PaO/FiO ratio ≤ 240 was robustly associated with longer hospitalization days (adjusted OR, 1.074; 95% CI, 1.01-1.143; = 0.024).
SAP with PaO/FiO ratio ≤ 240 is shown in significant relevance to the prolonged in-hospital stays among post-interventional patients. Older ages, baseline GCS scores of 3-8, and higher WBC counts after SAP diagnosis can independently predict the occurrence of SAP with a lower PaO/FiO ratio. Further validation studies are needed.
卒中相关性肺炎(SAP)常在缺血性卒中后发生。SAP病情恶化表现为动脉血氧分压(PaO)/吸入氧分数(FiO)比值降低,提示气体交换功能障碍。我们旨在研究接受血管内治疗的急性大血管闭塞(ALVO)患者中,低PaO/FiO比值的SAP的独立预测因素及预后情况。
我们回顾性分析了2020年12月至2022年12月期间,武汉市第一医院神经重症监护病房收治的连续成年ALVO介入治疗后患者的前瞻性数据。本研究纳入了未患新型冠状病毒肺炎的SAP患者,并将其分为两个亚组:PaO/FiO比值>240和≤240。主要结局为90天时神经功能良好(改良Rankin量表评分0-2分)。次要结局包括住院天数、症状性脑出血的发生情况以及90天死亡率。通过逻辑回归分析确定PaO/FiO比值≤240的SAP的独立危险因素及预后情况。
本研究共纳入159例发生SAP的患者:53例PaO/FiO比值>240,106例比值≤240。与PaO/FiO比值>240的患者相比,PaO/FiO比值≤240的患者年龄更大,基线美国国立卫生研究院卒中量表评分更高,基线格拉斯哥昏迷量表(GCS)评分为3-8分和洼田饮水试验分级≥3级的比例更高,白细胞(WBC)计数更高(所有P值<0.05)。PaO/FiO比值≤240的SAP的独立预测因素包括年龄(调整比值比[OR],1.043;95%置信区间[CI],1.011-1.077;P=0.009)、基线GCS评分为3-8分(调整OR,2.802;95%CI,1.214-6.465;P=0.016)以及SAP诊断后经自然对数转换的WBC计数(调整OR,3.977;95%CI,1.226-12.896;P=0.021)。PaO/FiO比值≤240的SAP与更长的住院天数密切相关(调整OR,1.074;95%CI,1.01-1.143;P=0.024)。
PaO/FiO比值≤240的SAP与介入治疗后患者住院时间延长显著相关。年龄较大、基线GCS评分为3-8分以及SAP诊断后WBC计数较高可独立预测低PaO/FiO比值的SAP的发生。需要进一步的验证研究。